Rune Grønseth

715 total citations
20 papers, 427 citations indexed

About

Rune Grønseth is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Rune Grønseth has authored 20 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Rune Grønseth's work include Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Tracheal and airway disorders (5 papers) and Pediatric health and respiratory diseases (4 papers). Rune Grønseth is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Tracheal and airway disorders (5 papers) and Pediatric health and respiratory diseases (4 papers). Rune Grønseth collaborates with scholars based in Norway, United States and Austria. Rune Grønseth's co-authors include Tomas Eagan, Per Bakke, Jon A. Hardie, Gunnar Reksten Husebø, Ane Johannessen, Amund Gulsvik, Marianne Aanerud, William M. Vollmer, A. Sonia Buist and Paul Enright and has published in prestigious journals such as PLoS ONE, European Respiratory Journal and Epidemiology.

In The Last Decade

Rune Grønseth

20 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rune Grønseth Norway 11 299 127 72 58 39 20 427
Hyung Koo Kang South Korea 13 285 1.0× 87 0.7× 23 0.3× 146 2.5× 10 0.3× 59 512
Noël Lampron Canada 12 455 1.5× 297 2.3× 20 0.3× 213 3.7× 32 0.8× 25 663
Simon Doe United Kingdom 12 244 0.8× 90 0.7× 54 0.8× 46 0.8× 13 0.3× 35 401
Élisabeth Rousseau Canada 9 85 0.3× 106 0.8× 18 0.3× 30 0.5× 21 0.5× 20 373
Haluk Türktaş Türkiye 15 455 1.5× 460 3.6× 12 0.2× 55 0.9× 25 0.6× 50 729
Prasad Nagakumar United Kingdom 14 448 1.5× 415 3.3× 22 0.3× 89 1.5× 138 3.5× 55 682
Lars Christian Laursen Denmark 13 521 1.7× 387 3.0× 18 0.3× 43 0.7× 17 0.4× 23 709
Elpis Hatziagorou Greece 13 554 1.9× 146 1.1× 25 0.3× 85 1.5× 18 0.5× 89 731
Stefan Ebmeier New Zealand 8 419 1.4× 436 3.4× 16 0.2× 33 0.6× 39 1.0× 13 589
David R. Mink United States 14 548 1.8× 565 4.4× 38 0.5× 67 1.2× 52 1.3× 24 804

Countries citing papers authored by Rune Grønseth

Since Specialization
Citations

This map shows the geographic impact of Rune Grønseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rune Grønseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rune Grønseth more than expected).

Fields of papers citing papers by Rune Grønseth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rune Grønseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rune Grønseth. The network helps show where Rune Grønseth may publish in the future.

Co-authorship network of co-authors of Rune Grønseth

This figure shows the co-authorship network connecting the top 25 collaborators of Rune Grønseth. A scholar is included among the top collaborators of Rune Grønseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rune Grønseth. Rune Grønseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Husebø, Gunnar Reksten, Rune Grønseth, Sverre Lehmann, Birger Norderud Lærum, & Tomas Eagan. (2018). Pneumonia vs non-pneumonia in COPD exacerbations – different risks?. Epidemiology. PA2277–PA2277. 1 indexed citations
2.
Erdal, Marta Bivand, Ane Johannessen, Tomas Eagan, et al.. (2018). Costs of COPD exacerbations in a general population.. PA3157–PA3157. 3 indexed citations
3.
Husebø, Gunnar Reksten, Esteban C. Gabazza, Marianne Aanerud, et al.. (2018). Coagulation markers in COPD. Epidemiology. OA1937–OA1937. 5 indexed citations
4.
Husebø, Gunnar Reksten, Rune Grønseth, Lorena Lerner, et al.. (2017). Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD. European Respiratory Journal. 49(3). 1601298–1601298. 43 indexed citations
5.
Grønseth, Rune, et al.. (2017). The microbiome of COPD in protected, bronchoscopic airway samples. PA378–PA378. 1 indexed citations
6.
Grønseth, Rune, Harald G. Wiker, Yaxin Xue, et al.. (2017). Protected sampling is preferable in bronchoscopic studies of the airway microbiome. ERJ Open Research. 3(3). 19–2017. 29 indexed citations
7.
Aanerud, Marianne, et al.. (2017). Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients. Respiratory Research. 18(1). 164–164. 25 indexed citations
8.
Grønseth, Rune, Marta Bivand Erdal, Wan C. Tan, et al.. (2017). Unemployment in chronic airflow obstruction around the world: results from the BOLD study. European Respiratory Journal. 50(3). 1700499–1700499. 16 indexed citations
9.
Husebø, Gunnar Reksten, Per Bakke, Jon A. Hardie, Rune Grønseth, & Tomas Eagan. (2017). Risk factors for lung cancer in COPD. Epidemiology. PA1211–PA1211. 2 indexed citations
10.
Erdal, Marta Bivand, Ane Johannessen, Tomas Eagan, et al.. (2016). Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. International Journal of COPD. Volume 11. 2099–2108. 8 indexed citations
11.
Eagan, Tomas, Harald G. Wiker, Ingvild Haaland, et al.. (2016). Laboratory contamination in airway microbiome studies. PA3984–PA3984. 3 indexed citations
12.
Bakke, Per, et al.. (2016). Participation in research bronchoscopy: a literature review. European Clinical Respiratory Journal. 3(1). 29511–29511. 13 indexed citations
13.
Husebø, Gunnar Reksten, Per Bakke, Rune Grønseth, et al.. (2016). Macrophage migration inhibitory factor, a role in COPD. American Journal of Physiology-Lung Cellular and Molecular Physiology. 311(1). L1–L7. 19 indexed citations
14.
Bakke, Per, et al.. (2016). Complications and discomfort of bronchoscopy: a systematic review. European Clinical Respiratory Journal. 3(1). 33324–33324. 69 indexed citations
15.
Husebø, Gunnar Reksten, Per Bakke, Jon A. Hardie, et al.. (2014). Macrophage migration inhibitory factor (MIF), a biomarker in COPD?. European Respiratory Journal. 44(Suppl 58). P1484–P1484. 1 indexed citations
16.
Eagan, Tomas, Per Bakke, Ingvild Haaland, et al.. (2014). Fever, hospitalization and healthcare utilization after research bronchoscopy. European Respiratory Journal. 44(Suppl 58). P702–P702. 1 indexed citations
17.
Husebø, Gunnar Reksten, Per Bakke, Marianne Aanerud, et al.. (2014). Predictors of Exacerbations in Chronic Obstructive Pulmonary Disease - Results from the Bergen COPD Cohort Study. PLoS ONE. 9(10). e109721–e109721. 57 indexed citations
18.
Grønseth, Rune, Ingvild Haaland, Harald G. Wiker, et al.. (2014). The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences. European Clinical Respiratory Journal. 1(1). 26196–26196. 23 indexed citations
19.
Erdal, Marta Bivand, Ane Johannessen, Jan Erik Askildsen, et al.. (2014). Productivity losses in chronic obstructive pulmonary disease: a population-based survey. BMJ Open Respiratory Research. 1(1). e000049–e000049. 13 indexed citations
20.
Grønseth, Rune, William M. Vollmer, Jon A. Hardie, et al.. (2013). Predictors of dyspnoea prevalence: results from the BOLD study. European Respiratory Journal. 43(6). 1610–1620. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026